Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atreca Inc Cl A (NQ: BCEL )

0.3190 -0.0070 (-2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,219
Open 0.3230
Bid (Size) 0.3126 (1)
Ask (Size) 0.3300 (89)
Prev. Close 0.3260
Today's Range 0.3100 - 0.3407
52wk Range 0.3100 - 2.050
Shares Outstanding 39,156,584
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
From Atreca, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
-65.13%
-65.13%
1 Month
-13.78%
-13.78%
3 Month
-65.70%
-65.70%
6 Month
-74.07%
-74.07%
1 Year
-81.01%
-81.01%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
Via Benzinga
Analyst Expectations for Atreca's Future
Via Benzinga
Recap: Atreca Q1 Earnings
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
The Latest Analyst Ratings for Atreca
Via Benzinga
Preview: Atreca's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
From Atreca, Inc.
Via GlobeNewswire
3 Penny Stocks to Catapult You Into the Millionaires’ Club
Via InvestorPlace
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
From Atreca, Inc.
Via GlobeNewswire
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
From Atreca, Inc.
Via GlobeNewswire
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
From Atreca, Inc.
Via GlobeNewswire
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
From Atreca, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
Philip Morris To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
From Atreca, Inc.
Via GlobeNewswire
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
From Atreca, Inc.
Via GlobeNewswire
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
From Atreca, Inc.
Via GlobeNewswire
Why Is T2 Biosystems (TTOO) Stock Down 21% Today?
Via InvestorPlace
Why Is Atreca (BCEL) Stock Up Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.